Fingerprint
Dive into the research topics of 'Adjuvant nivolumab for stage III/IV melanoma: Evaluation of safety outcomes and association with recurrence-free survival'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adjuvant nivolumab for stage III/IV melanoma: Evaluation of safety outcomes and association with recurrence-free survival
Mario Mandala, James Larkin, Paolo Antonio Ascierto, Michele Del Vecchio, Helen Gogas, C. Lance Cowey, Ana Arance, Stéphane Dalle, Michael Schenker, Jean Jacques Grob, Vanna Chiarion-Sileni, Ivan Marquez, Marcus O. Butler, Anna Maria Di Giacomo, Jose Lutzky, Luis De La Cruz-Merino, Victoria Atkinson, Petr Arenberger, Andrew Hill, Leslie Fecher
Research output: Contribution to journal › Article › peer-review
8
Citations
(Web of Science)